CollPlant Biotechnologies (CLGN)
(Delayed Data from NSDQ)
$4.76 USD
-0.06 (-1.17%)
Updated Sep 24, 2024 03:43 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 12/4/24 |
---|---|
Current Quarter | -0.37 |
EPS Last Quarter | -0.37 |
Last EPS Surprise | -5.71% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.44 |
Next Year | -0.56 |
EPS (TTM) | -1.54 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.73M | 0.76M | 2.83M | 14.50M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 0.73M | 0.76M | 2.83M | 14.50M |
Low Estimate | 0.73M | 0.76M | 2.83M | 14.50M |
Year ago Sales | 0.04M | 0.30M | 10.96M | 2.83M |
Year over Year Growth Est. | 1,730.00% | 154.67% | -74.19% | 412.44% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.37 | -0.42 | -1.44 | -0.56 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.37 | NA | -1.44 | -0.56 |
High Estimate | -0.37 | -0.42 | -1.44 | -0.56 |
Low Estimate | -0.37 | -0.42 | -1.44 | -0.56 |
Year ago EPS | -0.38 | -0.42 | -0.62 | -1.44 |
Year over Year Growth Est. | 2.63% | 0.00% | -132.26% | 61.11% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 0 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.37 | -0.42 | -1.44 | -0.56 |
7 Days Ago | -0.37 | -0.42 | -1.44 | -0.56 |
30 Days Ago | -0.37 | -0.42 | -1.44 | -0.56 |
60 Days Ago | -0.38 | -0.42 | -1.46 | -0.50 |
90 Days Ago | -0.38 | -0.42 | -1.46 | -0.50 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.37 | -0.42 | -1.44 | -0.56 |
Zacks Consensus Estimate | -0.37 | -0.42 | -1.44 | -0.56 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.37 | -0.37 | -0.42 | -0.38 | NA |
Estimate | -0.35 | -0.35 | NA | -0.02 | NA |
Difference | -0.02 | -0.02 | NA | -0.36 | -0.13 |
Surprise | -5.71% | -5.71% | NA | -1,800.00% | -603.81% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more